BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million

Reuters03-20

March 20 (Reuters) - Visen Pharmaceuticals 2561.HK:

NUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 11.4 MILLION
FINAL OFFER PRICE UNDER GLOBAL OFFERING HK$68.80 PER SHARE
NUMBER OF HONG KONG OFFER SHARES UNDER GLOBAL OFFERING 4.6 MILLION

Further company coverage: 2561.HK

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2521624514?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-21 01:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2521624514","market":"us","top_or_hot":-1,"title":"BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million</title></head><body><p><span>March 20 (Reuters)</span><span> - </span>Visen Pharmaceuticals <span>2561.HK</span>:</p><ul><li><p>NUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 11.4 MILLION</p></li><li><p>FINAL OFFER PRICE UNDER GLOBAL OFFERING HK$68.80 PER SHARE</p></li><li><p>NUMBER OF HONG KONG OFFER SHARES UNDER GLOBAL OFFERING 4.6 MILLION</p></li></ul><p>Further company coverage: <span>2561.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-21 01:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million</title></head><body><p><span>March 20 (Reuters)</span><span> - </span>Visen Pharmaceuticals <span>2561.HK</span>:</p><ul><li><p>NUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 11.4 MILLION</p></li><li><p>FINAL OFFER PRICE UNDER GLOBAL OFFERING HK$68.80 PER SHARE</p></li><li><p>NUMBER OF HONG KONG OFFER SHARES UNDER GLOBAL OFFERING 4.6 MILLION</p></li></ul><p>Further company coverage: <span>2561.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nFWN3Q3146:1","article_id":"2521624514","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2521624514","pubTimestamp":1742491685,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 MillionMarch 20  - Visen Pharmaceuticals 2561.HK:NUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 11.4 MILLIONFINAL OFFER PRICE UNDER GLOBAL OFFERING HK$68.80 PER SHARENUMBER OF HONG KONG OFFER SHARES UNDER GLOBAL OFFERING 4.6 MILLIONFurther company coverage: 2561.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"BRIEF-Visen Pharmaceuticals表示全球发售的发售股份数目为1,140万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02561":0.9},"content_text":"BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 MillionMarch 20 (Reuters) - Visen Pharmaceuticals 2561.HK:NUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 11.4 MILLIONFINAL OFFER PRICE UNDER GLOBAL OFFERING HK$68.80 PER SHARENUMBER OF HONG KONG OFFER SHARES UNDER GLOBAL OFFERING 4.6 MILLIONFurther company coverage: 2561.HK ((Reuters.Briefs@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2521624514"}